Allarity Therapeutics(ALLR)
BOSTON, MA
DiagnosticsFocus: Cancer Treatments with Companion Diagnostics
Allarity Therapeutics is a life sciences company focused on Cancer Treatments with Companion Diagnostics.
Oncology
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
Drug Response Predictor®
Ovarian CancerClinical Trials (1)
NCT03877796Clinical Pre-screening Protocol for Ovarian Cancer
N/A2X-121 and dovitinib
Advanced Solid TumorsClinical Trials (1)
NCT05571969Study to Determine the Maximum Tolerated Dose (MTD) of PARPi 2X-121 Monotherapy and the MTD of Dovitinib in Combination With 2X-121 in Patients With Advanced Solid Tumors
Phase 1Phase 1/2
Clinical Trials (1)
NCT01861496Phase I/II Study to Evaluate the Safety and Tolerability of LiPlaCis in Patients With Advanced or Refractory Tumours
Phase 1/2Phase 1/2
Clinical Trials (1)
NCT03196947Safety and Pharmacokinetics of Rising Doses of APO010 in Relapsed/Refractory Multiple Myeloma Patients Selected by DRP
Phase 1/2Ixabepilone Injection
Metastatic Breast CancerClinical Trials (1)
NCT04796324Anti-tumor Effect of Ixabepilone in Metastatic Breast Cancer (mBC) Selected by the Ixabepilone DRP.
Phase 2PARP inhibitor 2X-121
Metastatic Breast CancerClinical Trials (1)
NCT03562832Investigation of Anti-tumour Effect and Tolerability of the PARP Inhibitor 2X-121 in Patients With Metastatic Breast Cancer Selected by the 2X-121 DRP
Phase 2Phase 2
2X-121
Advanced Ovarian CancerClinical Trials (1)
NCT03878849Investigation of the Anti-tumor Effect of 2X-121 in Patients With Recurrent, Advanced Ovarian Cancer
Phase 2Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 7 clinical trials
SEC Filings: 2 available